Cargando…
Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
The diagnostic performance of the widely-used Cervista HPV HR test was compared to the Hybrid Capture 2 (HC2) test in a Dutch population-based cervical cancer screening program. In 900 scrapings of women with normal cytomorphology, specificity was 90% (95%CI: 87.84–91.87) for the Cervista HPV HR tes...
Autores principales: | Boers, Aniek, Slagter-Menkema, Lorian, van Hemel, Bettien M., Belinson, Jerome L., Ruitenbeek, Teus, Buikema, Henk J., Klip, Harry, Ghyssaert, Hilde, van der Zee, Ate G. J., de Bock, Geertruida H., Wisman, G. Bea A., Schuuring, Ed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106783/ https://www.ncbi.nlm.nih.gov/pubmed/25051098 http://dx.doi.org/10.1371/journal.pone.0101930 |
Ejemplares similares
-
Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media
por: Min, Kyung-Jin, et al.
Publicado: (2012) -
A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off
por: Boehmer, Gerd, et al.
Publicado: (2014) -
Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer
por: Dieleman, Marjolein, et al.
Publicado: (2021) -
DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
por: Boers, A, et al.
Publicado: (2014) -
Clinical validation of the Cervista(®) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
por: Mao, Xiaodan, et al.
Publicado: (2018)